Postdoctorante at Université de Caen Normandie, France
Dr. Caroline Lahogue is a dedicated researcher specializing in neuroscience, particularly focused on pharmacological treatments for Alzheimer’s disease and schizophrenia. She has held positions as a research engineer at the COMETE laboratory (UMRS 1075) and is currently completing her doctoral studies in Neuroscience. Her notable contributions include several impactful publications, such as exploring the role of 5-HT6 receptors in cognitive deficits and developing non-invasive drug administration methods in animal models. Dr. Lahogue has presented her research at numerous prestigious conferences and has been recognized as a finalist in the regional “Ma Thèse en 180 secondes” competition. Additionally, she is actively involved in scientific communication and outreach, engaging students and the public in neuroscience topics. Her skills encompass electrophysiology, behavioral analysis, and molecular biology, complemented by her commitment to advancing scientific knowledge and fostering collaboration within the research community.
Professional Profile:
Education🎓
Dr. Caroline Lahogue’s educational background reflects her strong foundation in neuroscience and biological sciences. She earned her Bachelor’s degree in Cellular Biology and Animal Physiology from the University of Reims Champagne-Ardenne in 2018, followed by a BTS in Medical Biology Analysis from Lycée Hugues Libergier, Reims, in 2017. She then pursued a Master’s degree in Cognitive Neurosciences at the University of Strasbourg, where she developed a therapeutic proof of concept against psychotic transitions using electrical neuromodulation. Dr. Lahogue completed her Ph.D. in Life Sciences and Health, specializing in Neuroscience, at the University of Caen in 2023. Her doctoral thesis focused on treatment strategies targeting 5-HT6 receptors in an innovative animal model of schizophrenia, showcasing her commitment to addressing complex neurological disorders. Through her education, Dr. Lahogue has gained expertise in experimental methodologies and research techniques, positioning her as a prominent figure in her field.
Professional Experience 💼
Dr. Caroline Lahogue has accumulated extensive professional experience in neuroscience research. She began her career as a laboratory technician at BIOXA in Reims in 2018, where she was involved in sample preparation and analysis. From 2020 to 2023, she served as a research engineer at the COMETE Laboratory (UMRS 1075) in Caen, focusing on pharmacological agents for treating Alzheimer’s disease. During her doctoral studies, she developed a specialized treatment strategy targeting 5-HT6 receptors in innovative animal models of schizophrenia, contributing to advancements in the field. Dr. Lahogue has co-authored several research articles published in prestigious journals, including a notable work on schizophrenia models in “Neuroscience & Biobehavioral Reviews.” Additionally, she has presented her findings at international conferences, demonstrating her ability to communicate complex scientific concepts effectively. Her roles also include mentoring students and engaging in public outreach initiatives, emphasizing her commitment to both research and education.
Research interest🔍
Dr. Caroline Lahogue’s research interests primarily focus on neuroscience, with a particular emphasis on the pharmacological treatment of neuropsychiatric disorders. Her doctoral work investigates the therapeutic potential of 5-HT6 receptor modulation in innovative animal models of schizophrenia, aiming to understand the underlying mechanisms of cognitive deficits associated with the disorder. Additionally, she explores the in vivo and ex vivo effects of novel pleiotropic pharmacological agents for Alzheimer’s disease treatment, contributing to the search for effective therapies. Dr. Lahogue employs a variety of experimental techniques, including electrophysiological recordings and behavioral assessments, to evaluate synaptic activity and cognitive functions in animal models. Her work not only seeks to advance the understanding of these complex conditions but also aims to facilitate the development of targeted therapeutic strategies. Through her research, Dr. Lahogue aspires to make significant contributions to the fields of psychopharmacology and neurobiology, addressing critical challenges in mental health.
Award and Honor🏅
Dr. Caroline Lahogue has received several awards and honors throughout her academic and research career, recognizing her significant contributions to neuroscience. Notably, she was a finalist in the regional competition “Ma Thèse en 180 secondes” (MT180) in 2023, showcasing her ability to communicate complex scientific concepts effectively and engagingly. Dr. Lahogue’s presentations at prestigious conferences, such as the 14th Federation of European Neuroscience Societies Forum, have further highlighted her innovative research on pharmacological treatments for neuropsychiatric disorders. She has been actively involved in promoting science through various outreach initiatives, such as managing workshops during the “Fête de la Science” and “Semaine du Cerveau,” aimed at increasing public awareness of neuroscience. As a representative of her doctoral school, she has played a pivotal role in fostering communication and collaboration among peers. These accolades and her dedication to science communication demonstrate her commitment to advancing neuroscience and engaging with the wider community.
Conclusion
Caroline Lahogue’s strong academic background, substantial research contributions, effective communication skills, and commitment to scientific outreach make her an excellent candidate for the Best Researcher Award. By focusing on expanding her network, improving her language skills, and considering interdisciplinary collaborations, she can further enhance her research profile. Overall, her achievements and potential position her as a promising researcher in the field of neuroscience, deserving of recognition.
Publications top noted📜
- Title: The 3-hit animal models of schizophrenia: Improving strategy to decipher and treat the disease?
Authors: Percelay, S., Lahogue, C., Billard, J.-M., Boulouard, M., Bouet, V.
Year: 2024
Citation: Neuroscience and Biobehavioral Reviews, 157, 105526.
- Title: Micropipette-guided Drug Administration (MDA) as a non-invasive chronic oral administration method in male rats
Authors: Heraudeau, M., Roux, C.M., Lahogue, C., Lelong-Boulouard, V., Freret, T.
Year: 2023
Citation: Journal of Neuroscience Methods, 398, 109951.
- Title: 5-HT6 Receptors Sex-Dependently Modulate Hippocampal Synaptic Activity through GABA Inhibition
Authors: Lahogue, C., Billard, J.-M., Freret, T., Bouet, V.
Year: 2023
Citation: Biomolecules, 13(5), 751.
- Title: Frontoparietal anodal tDCS reduces ketamine-induced oscillopathies
Authors: Lahogue, C., Pinault, D.
Year: 2021
Citation: Translational Neuroscience, 12(1), pp. 282–296.
